- Research works
- 29 ▲ 14% vs 2013–17
- Citations
- 749 26.1 per fractional work
- Top-10% rate
- 12.1% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: Palobiofarma (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.0×. Every wedge is a field page.
Which keywords describe research at Palobiofarma (Spain)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Tumor Microenvironment, Cancer, Cardiovascular Risk, Antioxidant, Chemoprevention, Biogeography and Phylogeny.
- molecular systematics
- Medicinal Plants
- HPV Vaccination
- Brassicaceae
- Oxidative Stress
- Global Burden
- Taxonomy
- Adenosine Receptors
- Cyclooxygenase-2 Inhibitors
- Clinical Trials
- Neuroprotection
- Chemoprevention
- Antioxidant
- Epidemiology
- Cancer
- Inflammation
- Tumor Microenvironment
- Cardiovascular Risk
- Biogeography
- Phylogeny
- Therapeutic Targets
- Pharmacology
- Prostaglandins
- Purinergic Signalling
- Cervical Cancer
- Metabolism
- Treatment
- Ethical Climate
- Human Papillomavirus
- Moral Distress
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 30 words, with their numbers
- Inflammation5▲ 8.1×11 topics
- Cancer2▲ 6.3×4 topics
- Tumor Microenvironment2▲ 24×4 topics
- Epidemiology2▲ 2.0×8 topics
- Cardiovascular Risk2▲ 19×3 topics
- Antioxidant2▲ 9.1×6 topics
- Biogeography2▲ 17×3 topics
- Chemoprevention2▲ 68×2 topics
- Phylogeny2▲ 32×3 topics
- Neuroprotection2▲ 14×4 topics
- Therapeutic Targets2▲ 24×2 topics
- Clinical Trials2▲ 8.3×5 topics
- Pharmacology2▲ 15×6 topics
- Cyclooxygenase-2 Inhibitors1▲ 125×1 topic
- Prostaglandins1▲ 125×1 topic
- Adenosine Receptors1▲ 172×1 topic
- Purinergic Signalling1▲ 172×1 topic
- Taxonomy1▲ 27×2 topics
- Cervical Cancer1▲ 38×2 topics
- Global Burden1▲ 7.1×2 topics
- Metabolism1▲ 6.0×5 topics
- Oxidative Stress1▲ 2.0×6 topics
- Treatment1▲ 3.0×4 topics
- Brassicaceae1▲ 468×1 topic
- Ethical Climate1▲ 83×1 topic
- HPV Vaccination1▲ 71×1 topic
- Human Papillomavirus1▲ 29×1 topic
- Medicinal Plants1▲ 9.4×3 topics
- Moral Distress1▲ 83×1 topic
- molecular systematics1▲ 136×1 topic
Which research topics does Palobiofarma (Spain) publish most on?
By volume in 2022–2025: Adenosine and Purinergic Signaling, Peptidase Inhibition and Analysis, Data Privacy and Cybersecurity and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Adenosine and Purinergic Signaling Physiology 0 works
- 2 Peptidase Inhibition and Analysis Oncology 0 works
- 3 Data Privacy and Cybersecurity Law 0 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 5 Administrative Law and Governance Political Science and International Relations 0 works
- 6 Agriculture and Biological Studies General Agricultural and Biological Sciences 0 works
- 7 Genetic diversity and population structure Genetics 0 works
- 8 Botanical Studies and Applications Plant Science 0 works
- 9 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
- 10 Palliative and Oncologic Care Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Palobiofarma (Spain)'s research output changed?
Output in 2018–2022 was 14% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mataró
- Universitat de Barcelona
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- Hospital Clínic de Barcelona
- Vall d'Hebron Hospital Universitari
- Hospital de Sant Pau
- Universitat Oberta de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.